Latest Regulatory Filings News

Page 47 of 54
Cleo Diagnostics reports steady progress in its U.S. and Australian clinical trials for an ovarian cancer blood test, maintaining a solid cash reserve of A$7.3 million as it prepares for FDA submission.
Ada Torres
Ada Torres
31 Jan 2025
Epsilon Healthcare's December 2023 quarterly report reveals significant boardroom conflict and governance breaches, yet operational segments show promising growth.
Ada Torres
Ada Torres
31 Jan 2025
Epsilon Healthcare Limited reported a modest cash increase in its December quarter but remains under administration with no unused financing facilities, raising questions about its operational future.
Ada Torres
Ada Torres
31 Jan 2025
Tombador Iron Limited reported a modest net cash outflow of $317,000 for the December 2024 quarter, yet holds robust cash reserves of $10.825 million, underpinning over 34 quarters of operational funding.
Maxwell Dee
Maxwell Dee
31 Jan 2025
Alchemy Resources Limited reported a slight $15,000 cash outflow in its December 2024 quarter, maintaining a solid cash balance of $2 million as it continues to invest in exploration activities.
Maxwell Dee
Maxwell Dee
31 Jan 2025
Oakridge International Limited reports a strong quarterly performance driven by increased contracted orders, strategic partnerships, and technological innovation, positioning the company for sustained growth into 2025.
Victor Sage
Victor Sage
31 Jan 2025
True North Copper Limited reported a significant cash outflow in the December 2024 quarter, driven by high operating expenses linked to voluntary administration and exploration activities. Despite ending the quarter with $19.12 million in cash, the company’s negative operating cash flow signals ongoing financial pressure.
Maxwell Dee
Maxwell Dee
31 Jan 2025
Ark Mines Ltd reported a significant cash outflow in its December 2024 quarter, prompting plans for a capital raising to support ongoing exploration activities.
Maxwell Dee
Maxwell Dee
31 Jan 2025
Freehill Mining Ltd’s December quarter cash flow report reveals a $114,000 net cash outflow from operations but highlights a solid liquidity position with $301,000 in unused financing facilities.
Maxwell Dee
Maxwell Dee
31 Jan 2025
Tissue Repair Limited reports initial patient enrolment in its pivotal Phase 3 trial for TR987®, alongside a robust 35% quarterly sales increase for its TR Pro+® product. The company is also advancing manufacturing and distribution strategies to support growth.
Ada Torres
Ada Torres
31 Jan 2025
Emperor Energy Limited reported a net operating cash outflow of $376,000 for the December quarter but bolstered its cash reserves with a $3.6 million financing inflow, ending the period with $3.4 million in cash.
Maxwell Dee
Maxwell Dee
31 Jan 2025
Opthea Limited reports steady progress in its Phase 3 trials for sozinibercept, a novel treatment for wet AMD, supported by a strong cash position and a recent R&D tax incentive.
Victor Sage
Victor Sage
31 Jan 2025